Hygea VCT plc
Overview
Hygea VCT was launched in 2001 as BioScience VCT to invest in bioscience companies, with a particular focuis on investing in treatment development companies. Since then, the Board has shifted emphasis to investing in medical technology companies (eg devices, drug delivery systems, diagnostics etc). The investment strategy is to seek companies with the potential to conform to certain key criteria including; an industry relevant team, competitive value to customers, scalability in global markets and a recurring business revenue model. Comapnies in which the VCT has invested to date include; Immunodiagnostics plc, Epistem Holdings plc, Omega Diagnostics Group plc, Prosurgics Ltd, Hallmarq Veterinary Imaging, Scancell plc, DxS and BioAnaLab Ltd.
Historic Prices
No auction history
Auctions
| Next auction date | Indicative price | Highest bid (p) | Lowest offer (p) | Market type | Auction frequency | Next auction time |
| 25 Mar 10 | n/a | n/a | n/a | Open | Monthly | 5:00pm |
Announcements
| Title | Date |
| Corporate Update | 27 Jan 10 |
| Declaration of Interim Dividend | 22 Jan 10 |
| Apppointment of Corporate Broker | 04 Dec 09 |
Report & accounts
| Title | Date |
| Report and Accounts to December 2008 | 09 Nov 09 |
| Report and Accounts to December 2007 | 09 Nov 09 |
| Report and Accounts To December 2006 | 09 Nov 09 |
Fundamentals
| Year ending | Sales (£m) | Pre-tax profit (£m) |
| 31 Dec 2008 | N/A | 0.4180 |
Directors
| Name |
| James Otter (Chairman) |
| John Hustler |
| Charles Breese |
Website
www.hygeavct.com